Nytt styremedlem Dr. Volck, M.D., Ph.D. med sinnsykt imponerende erfaring og connections til store selskap (hinthint):


Dr. Volck has over 20 years of leadership experience in the biotechnology and pharmaceutical industry.

- She has held various positions at Amgen Inc., including Executive Development Director, Bone, Neuroscience & Inflammation

=> Market Cap 142 MILLIARDER DOLLAR


- Before that, Dr. Volck was the Chief Medical Officer and Senior Vice President of Development at Swedish Orphan Biovitrum AB.

=> Market Cap 40,65 MILLIARDER SEK!


- Volck has served as the President R&D at AVROBIO Inc. (Nasdaq) => Market Cap 374 MUSD


- Prior to this, she served as head of Research and Development, Rare Diseases, for GlaxoSmithKline.

=> Market Cap 7,8 Mrd


- She served as Nordic Medical Director and Project Director at Genzyme A/S.


- She currently serves as Director of Ascendis Pharma A/S (Nasdaq) and Soleno Therapeutics Inc. (Nasdaq).

=> Market cap på hhv. 7,4 MRD DKK og 720 mill kr